Meera Ragavan to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Meera Ragavan has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.209
-
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic. JAMA Oncol. 2022 12 01; 8(12):1849-1851.
Score: 0.209